Intra-Cellular Therapies
ITCI
#1267
Rank
โ‚น1.200 T
Marketcap
โ‚น11,268
Share price
0.05%
Change (1 day)
97.95%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -โ‚น132.73

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -โ‚น137.56. In 2022 the company made an earnings per share (EPS) of -โ‚น232.41 an increase over its 2021 EPS that were of -โ‚น299.05.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น132.73-42.89%
2022-โ‚น232.41-22.29%
2021-โ‚น299.058.02%
2020-โ‚น276.8420.9%
2019-โ‚น228.99-5.63%
2018-โ‚น242.6633.96%
2017-โ‚น181.14-21.19%
2016-โ‚น229.84-7.56%
2015-โ‚น248.64174.53%
2014-โ‚น90.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น21.36-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น854.44 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น182.85 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA